Not Yet RecruitingNot Applicable

Study of The Analgesic Profile of Two Adjuvants Added to Low Dose Hyperbaric Bupivacaine Versus One Adjuvant in Patients Undergoing Anal Surgery Using Spinal Anesthesia

Egypt60 participantsStarted 2025-08

Plain-language summary

This study will be conducted to compare the efficacy of fentanyl and Dexmedetomidine as an additive to hyperbaric bupivacaine 0.5% in saddle block anesthesia on duration of analgesia in patients undergoing anorectal surgeries.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * aged from 18 to 65 years * American Society of Anesthesiologists' physical I or II of both sexes * Patients who will be scheduled to surgery for their uncomplicated hemorrhoids, anal fissure, or anal fistula in lithotomy position will be included in the study. Exclusion Criteria: * Infection focus at back, history of spine surgery, coagulopathy, mental disturbance, and neurological disease. * drug allergy. * intake of experimental or analgesic medication within last 24 hours. * patients receiving alpha-adrenergic antagonist will be excluded from the study.

What they're measuring

Duration of analgesia

Timeframe: 2 hours

Trial details

NCT IDNCT07114263

SponsorTanta University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-02

Contact for this trial

Ezzat Alhelw, Resident

+20 10 06489620 ezzatnasr136@gmail.com

View on ClinicalTrials.gov More Spinal Anesthesia Administration trials